高级检索
当前位置: 首页 > 详情页

Ketogenic diet: a potential adjunctive treatment for substance use disorders

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Gen Hosp Eastern Theater Command, Nanjing, Peoples R China [2]Yunnan Univ, Yunnan Technol Innovat Ctr Drug Addict Med, Kunming, Peoples R China [3]Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China [4]Drug Rehabil Hosp Kunming City, Peoples Hosp Kunming City 3, Kunming, Peoples R China
出处:
ISSN:

关键词: ketogenic diet substance use disorders addiction metabolism neuroprotection gut microbiota

摘要:
Substance use disorders (SUD) can lead to serious health problems, and there is a great interest in developing new treatment methods to alleviate the impact of substance abuse. In recent years, the ketogenic diet (KD) has shown therapeutic benefits as a dietary therapy in a variety of neurological disorders. Recent studies suggest that KD can compensate for the glucose metabolism disorders caused by alcohol use disorder by increasing ketone metabolism, thereby reducing withdrawal symptoms and indicating the therapeutic potential of KD in SUD. Additionally, SUD often accompanies increased sugar intake, involving neural circuits and altered neuroplasticity similar to substance addiction, which may induce cross-sensitization and increased use of other abused substances. Reducing carbohydrate intake through KD may have a positive effect on this. Finally, SUD is often associated with mitochondrial damage, oxidative stress, inflammation, glia dysfunction, and gut microbial disorders, while KD may potentially reverse these abnormalities and serve a therapeutic role. Although there is much indirect evidence that KD has a positive effect on SUD, the small number of relevant studies and the fact that KD leads to side effects such as metabolic abnormalities, increased risk of malnutrition and gastrointestinal symptoms have led to the limitation of KD in the treatment of SUD. Here, we described the organismal disorders caused by SUD and the possible positive effects of KD, aiming to provide potential therapeutic directions for SUD.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2024]版:
最新[2023]版:
大类 | 2 区 农林科学
小类 | 3 区 营养学
JCR分区:
出版当年[2023]版:
Q2 NUTRITION & DIETETICS
最新[2023]版:
Q2 NUTRITION & DIETETICS

影响因子: 最新[2023版] 最新五年平均 出版当年[2023版] 出版当年五年平均 出版前一年[2022版]

第一作者:
第一作者机构: [1]Gen Hosp Eastern Theater Command, Nanjing, Peoples R China [2]Yunnan Univ, Yunnan Technol Innovat Ctr Drug Addict Med, Kunming, Peoples R China [3]Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China
共同第一作者:
通讯作者:
通讯机构: [1]Gen Hosp Eastern Theater Command, Nanjing, Peoples R China [2]Yunnan Univ, Yunnan Technol Innovat Ctr Drug Addict Med, Kunming, Peoples R China [3]Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53621 今日访问量:0 总访问量:1665 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)